MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway

被引：0
|
作者：
Zhenyu Zhang
Jinfeng Zhu
Yansong Huang
Weibing Li
Hongqiu Cheng
机构：
[1] Shenzhen Pingshan District People’s Hospital,Department of Traditional Chinese Medicine
[2] Nantong Hospital of Traditional Chinese Medicine,Department of Traditional Chinese Medicine
[3] The Second Affiliated Hospital of Shantou University Medical College,Department of Infectious Diseases
来源：
Diagnostic Pathology | / 13卷
关键词：
Hepatocellular carcinoma; PI3K/AKT/mTOR signaling pathway; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhang, Zhenyu
    Zhu, Jinfeng
    Huang, Yansong
    Li, Weibing
    Cheng, Hongqiu
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [2] PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
    Ding, Yifeng
    Wang, Xiaoqing
    Shu, Fei
    Pan, Kehua
    Chen, Xiaohong
    Liu, Qingquan
    JOURNAL OF MOLECULAR HISTOLOGY, 2024, 55 (06) : 1107 - 1120
  • [3] VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
    Zhangya Pu
    Dan G. Duda
    Yuanyuan Zhu
    Siya Pei
    Xiaofang Wang
    Yan Huang
    Panpan Yi
    Zebing Huang
    Fang Peng
    Xingwang Hu
    Xuegong Fan
    Journal of Translational Medicine, 20
  • [4] VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
    Pu, Zhangya
    Duda, Dan G.
    Zhu, Yuanyuan
    Pei, Siya
    Wang, Xiaofang
    Huang, Yan
    Yi, Panpan
    Huang, Zebing
    Peng, Fang
    Hu, Xingwang
    Fan, Xuegong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [5] LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway
    Wu, J. -H.
    Tian, X. -Y.
    An, Q-M.
    Guan, X. -Y.
    Hao, C. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1645 - 1652
  • [6] GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway
    Wang, Yadong
    Fang, Xiaosan
    Xie, Hao
    Wang, Xiaoming
    BIOCHEMICAL GENETICS, 2024,
  • [7] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
    Yu, Xinxin
    Zheng, Yan
    Zhu, Xuchao
    Gao, Xiaomei
    Wang, Chaoqun
    Sheng, Yuanyuan
    Cheng, Wei
    Qin, Lunxiu
    Ren, Ning
    Jia, Huliang
    Dong, Qiongzhu
    ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
  • [8] FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
    Jiang, Kun
    Xu, Li-zhe
    Ning, Jin-zhuo
    Cheng, Fan
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [9] COPS8 promotes hepatocellular carcinoma progression through the PI3K/AKT/mTOR pathway
    Yan, Xiaodong
    Li, Zhongmin
    Tian, Qing
    Zhang, Yamin
    ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2947 - 2949
  • [10] FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
    Kun Jiang
    Li-zhe Xu
    Jin-zhuo Ning
    Fan Cheng
    Cancer Cell International, 23
12345